Delphinidin-3-O-arabinoside chloride is an anthocyanin chloride compound. It is formed by combining Delphinidin (an anthocyanin with a natural purple color) with the 3-O-arabinoside group. Delphinidin-3-O-arabinoside can be isolated from Rhododendron and is in the form of furanose.

Icosabutate (NST-4016) is an orally active derivative of eicosapentaenoic acid that inhibits hepatic inflammation and fibrosis in NASH, improves cardiovascular risk profiles in statin-treated patients with residual hypertriglyceridemia, lowers triglycerides, and may be useful in studies of liver fibrosis and atherosclerosis.

Cixutumumab (IMC-A12), a humanized monoclonal antibody targeting IGF-1R, exhibits high affinity and inhibits ligand-dependent receptor activation, impeding downstream signaling.